EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Transeptal Mitral Annuloplasty With the AMEND System: 6-Month Results of First in Man Cohort

Bruno Melica iD, Shemy Carasso iD, Adi Butnaru, Irakli Gogorishvili iD, Mikhael Metreveli, Thomas Modine iD, Levan Kurashvili, Rivka Farkash, David Meerkin iD

Circulation: Cardiovascular Interventions · 2026-06 · 19 (6)

DOI: 10.1161/circinterventions.125.015977 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026-06. Verfasst von Bruno Melica und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Vila Nova de Gaia/Espinho Hospital Center, Portugal (B.M.). Hauptthemen laut MEDLINE: Mitral Valve, Mitral Valve Annuloplasty, Mitral Valve Insufficiency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The AMEND implant is a semi-rigid closed D-shaped annuloplasty ring deployed through a transvenous transeptal approach. It is aimed to affect selective anteroposterior dimensional reduction, improving leaflet coaptation, and reduce mitral regurgitation (MR). We report the 6-month outcomes of the first cohort treated. METHODS: Thirteen patients with the grade 3 or 4 functional MR were treated in 2 studies in Georgia and Israel, and with compassionate approvals in Portugal and France. They underwent mitral repair with the AMEND annuloplasty and were followed for 6 months. RESULTS: There were no deaths, myocardial infarctions, strokes or cardiac surgery. There were 2 pericardial effusions, 1 acute and the second at 4 months. There was no anchor disengagement or device dehiscence over the follow-up period. There was a single patient who was readmitted with heart failure, and the iatrogenic atrial septal defect was closed. At 6 months the overall anteroposterior dimensional reduction achieved acutely was maintained, with MR reduction being stable, with 11 of 13 patients with ≤grade 1 MR. CONCLUSIONS: In this small multicenter cohort of patients, the AMEND annuloplasty procedure demonstrated promising safety, with stable and significant reduction of MR maintained over the 6-month follow-up period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral ValveMitral Valve AnnuloplastyMitral Valve InsufficiencyAgedFemaleHumansMaleMiddle AgedCompassionate Use TrialsFranceHeart Valve ProsthesisIsraelPortugalProsthesis DesignRecovery of FunctionTime FactorsTreatment Outcome

Stichwörter der Autor:innen

heart failurehumansmitral valve insufficiencymyocardial infractionpericardial effusion

Autor:innen und Institutionen

  • Department of Cardiology, Vila Nova de Gaia/Espinho Hospital Center, Portugal (B.M.).
  • Jesselson Integrated Heart Center, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Israel (S.C.).
  • Lev Leviev Heart Institute, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel (A.B.).
  • Healthycore Medical Center, Tbilisi, Georgia (I.G., M.M.). American Hospital Tbilisi, Georgia.
  • Department of Cardiology and Cardio-Vascular Surgery, Hôpital Cardiologique de Haut-Lévêque, Bordeaux University Hospital, Pessac, France (T.M.).
  • Tbilisi Institute of Medicine, Ilia State University Medical School, Tbilisi Heart and Vascular Clinic, Georgia (L.K.).

ORCID-Profile: Bruno Melica, Shemy Carasso, Irakli Gogorishvili, Thomas Modine, David Meerkin

Zitieren

APA

Melica, B., Carasso, S., Butnaru, A., Gogorishvili, I., Metreveli, M., Modine, T., Kurashvili, L., Farkash, R., & Meerkin, D. (2026). Transeptal Mitral Annuloplasty With the AMEND System: 6-Month Results of First in Man Cohort. Circulation: Cardiovascular Interventions, 19(6). https://doi.org/10.1161/circinterventions.125.015977

Vancouver

Melica B, Carasso S, Butnaru A, Gogorishvili I, Metreveli M, Modine T, et al. Transeptal Mitral Annuloplasty With the AMEND System: 6-Month Results of First in Man Cohort. Circulation: Cardiovascular Interventions. 2026;19(6). doi:10.1161/circinterventions.125.015977

BibTeX
@article{Melica2026,
  author = {Melica, Bruno and Carasso, Shemy and Butnaru, Adi and Gogorishvili, Irakli and Metreveli, Mikhael and Modine, Thomas and Kurashvili, Levan and Farkash, Rivka and Meerkin, David},
  title = {Transeptal Mitral Annuloplasty With the AMEND System: 6-Month Results of First in Man Cohort},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2026},
  volume = {19},
  number = {6},
  doi = {10.1161/circinterventions.125.015977}
}
Kostenlos starten →